274.28 0.00 (0.00%)
After hours: 4:57PM EDT
|Bid||274.30 x 1000|
|Ask||315.06 x 800|
|Day's Range||268.25 - 275.05|
|52 Week Range||176.11 - 275.05|
|Beta (3Y Monthly)||1.26|
|PE Ratio (TTM)||62.05|
|Earnings Date||Jul 30, 2019 - Aug 5, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||267.20|
Jon Ayers became the CEO of IDEXX Laboratories, Inc. (NASDAQ:IDXX) in 2002. First, this article will compare CEO...
The government requires hedge funds and wealthy investors that crossed the $100 million equity holdings threshold are required to file a report that shows their positions at the end of every quarter. Even though it isn't the intention, these filings level the playing field for ordinary investors. The latest round of 13F filings disclosed the […]
Idexx Laboratories Inc NASDAQ/NGS:IDXXView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is extremely low for IDXX with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting IDXX. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding IDXX totaled $13.75 billion. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
For his Executive Decision segment of "Mad Money" Wednesday our own Jim Cramer sat down with Jonathan Ayers, chairman, president and CEO of Idexx Laboratories Inc. IDXX, an animal health company. For those pets who do see their vet, however, diagnostics from Idexx are becoming an integral part of their care. Ayers said Idexx continues to innovate, which helps it see strong organic growth and increased operating margins.
"[Millennials] are more likely to go to the vet more frequently and more willing to listen to an advanced standard of care," CEO Jonathan Ayers says. About 42% of millennials think their pets have special health needs — more than double the percentage of the baby boomer generation, he said. Idexx Laboratories IDXX has room to grow in providing preventative care for pets, CEO Jonathan Ayers told CNBC Wednesday.
WESTBROOK, Maine , May 20, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will participate ...
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift...
Chairman, President & CEO of Idexx Laboratories Inc (NASDAQ:IDXX) Jonathan W Ayers sold 28,000 shares of IDXX on 05/03/2019 at an average price of $249.02 a share.
IDEXX Laboratories is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
On CNBC's "Mad Money Lightning Round," Jim Cramer said he is not a trucker fan and he wants to stay away from Knight-Swift Transportation Holdings Inc (NYSE: KNX ). Cramer prefers Barrick Gold ...
Idexx (IDXX) delivered earnings and revenue surprises of 12.50% and 0.83%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
On a per-share basis, the Westbrook, Maine-based company said it had net income of $1.17. The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment ...
WESTBROOK, Maine , May 1, 2019 /PRNewswire/ -- Reports revenue growth of 7% on a reported basis and 10% on an organic basis, driven by CAG Diagnostics recurring revenue growth of 9% reported and 12% organic ...